{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:38:42Z","timestamp":1789742322422,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lfs.2024.122441","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:16:07Z","timestamp":1705742167000},"page":"122441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Nalbuphine-6-glucuronide is a potent analgesic with superior safety profiles by altering binding affinity and selectivity for mu-\/kappa-opioid receptors"],"prefix":"10.1016","volume":"340","author":[{"given":"Yen-Lun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eagle Yi-Kung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jaan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.lfs.2024.122441_bb0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0376-8716(85)90066-3","article-title":"Nalbuphine","volume":"14","author":"Schmidt","year":"1985","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.lfs.2024.122441_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-198326030-00002","article-title":"A preliminary review of its pharmacological properties and therapeutic efficacy","volume":"26","author":"Errick","year":"1983","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.lfs.2024.122441_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","article-title":"Opioid agonist-antagonist drugs in acute and chronic pain states","volume":"41","author":"Hoskin","year":"1991","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.lfs.2024.122441_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122441_bb0025","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s11095-013-1272-4","article-title":"Commonly used excipients modulate UDP-glucuronosyltransferase 2b7 activity to improve nalbuphine oral bioavailability in humans","volume":"31","author":"Wang","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2024.122441_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2015.03.020","article-title":"A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain","volume":"74","author":"Sverrisdottir","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2024.122441_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/med.20035","article-title":"Morphine-6-glucuronide: actions and mechanisms","volume":"25","author":"Kilpatrick","year":"2005","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2024.122441_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.2002.01554.x","article-title":"The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide","volume":"53","author":"Penson","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5 Suppl","key":"10.1016\/j.lfs.2024.122441_bb0045","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpainsymman.2005.01.004","article-title":"Opioid metabolites","volume":"29","author":"Lotsch","year":"2005","journal-title":"J. Pain Symptom Manag."},{"issue":"6","key":"10.1016\/j.lfs.2024.122441_bb0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/bja\/aeu186","article-title":"Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide","volume":"113","author":"Klimas","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers","volume":"73","author":"Skarke","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/bjc.1992.23","article-title":"Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide","volume":"65","author":"Hucks","year":"1992","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0065","first-page":"149","article-title":"Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms","volume":"232","author":"Ling","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.122441_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(85)91227-2","article-title":"Autoradiographic distribution of mu1 and mu2 opioid binding in the mouse central nervous system","volume":"360","author":"Moskowitz","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2024.122441_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11306-013-0605-y","article-title":"New finding of nalbuphine metabolites in men: NMR spectroscopy and UPLC\u2013MS\/MS spectrometry assays in a pilot human study","volume":"10","author":"Wang","year":"2014","journal-title":"Metabolomics"},{"key":"10.1016\/j.lfs.2024.122441_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105093","article-title":"A dual system platform for drug metabolism: nalbuphine as a model compound","volume":"141","author":"Liang","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122441_bb0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejmech.2019.06.028","article-title":"A novel finding of nalbuphine-6-glucuronide, an active opiate metabolite, possessing potent antinociceptive effects: synthesis and biological evaluation","volume":"178","author":"Liang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2024.122441_bb0090","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/laban1110-352","article-title":"Long-term subarachnoid catheter placement in the middle cranial fossa of the rat","volume":"39","author":"Ehlert","year":"2010","journal-title":"Lab. Anim. (NY)"},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0023677216646069","article-title":"Refinement of a model of repeated cerebrospinal fluid collection in conscious rats","volume":"51","author":"Amen","year":"2017","journal-title":"Lab. Anim."},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0100","first-page":"102","article-title":"An innovative cold tail-flick test: the cold ethanol tail-flick test","volume":"80","author":"Wang","year":"1995","journal-title":"Anesth. Analg."},{"issue":"5","key":"10.1016\/j.lfs.2024.122441_bb0105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.pnpbp.2005.11.036","article-title":"The four-plates test: anxiolytic or analgesic paradigm?","volume":"30","author":"Ripoll","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2024.122441_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170455","article-title":"LVV-hemorphin-7 (LVV-H7) plays a role in antinociception in a rat model of alcohol-induced pain disorders","volume":"136","author":"Hung","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2024.122441_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2550-y","article-title":"Fundamentals of pharmacokinetics to assess the correlation between plasma drug concentrations and different blood sampling methods","volume":"36","author":"Chen","year":"2019","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122441_bb0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jnc.12976","article-title":"Differential effects of exercise on brain opioid receptor binding and activation in rats","volume":"132","author":"Arida","year":"2015","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.lfs.2024.122441_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217371","article-title":"Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids","volume":"14","author":"Olson","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2024.122441_bb0130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1213\/01.ane.0000217197.96784.c3","article-title":"Morphine-6-glucuronide: morphine\u2019s successor for postoperative pain relief?","volume":"102","author":"van Dorp","year":"2006","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.lfs.2024.122441_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3959(91)90170-3","article-title":"Morphine-6-glucuronide: effects on ventilation in normal volunteers","volume":"45","author":"Peat","year":"1991","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.lfs.2024.122441_bb0140","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000542-200504000-00018","article-title":"Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery","volume":"102","author":"Hanna","year":"2005","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.122441_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(85)90317-6","article-title":"Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists","volume":"119","author":"Pizziketti","year":"1985","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122441_bb0150","first-page":"191","article-title":"The analgesic effect of nalbuphine and its long-acting prodrug, nalbuphine pivalate, in rats","volume":"40","author":"Chen","year":"2002","journal-title":"Acta Anaesthesiol. Sin."},{"issue":"50\u201351","key":"10.1016\/j.lfs.2024.122441_bb0155","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths-United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"50\u201351","key":"10.1016\/j.lfs.2024.122441_bb0160","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths - United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"2","key":"10.1016\/j.lfs.2024.122441_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/bja\/aen153","article-title":"Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging","volume":"101","author":"Machata","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"11","key":"10.1016\/j.lfs.2024.122441_bb0170","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1460-9592.2010.03419.x","article-title":"Upper airway size and configuration during propofol-based sedation for magnetic resonance imaging: an analysis of 138 infants and children","volume":"20","author":"Machata","year":"2010","journal-title":"Paediatr. Anaesth."},{"issue":"3","key":"10.1016\/j.lfs.2024.122441_bb0175","first-page":"252","article-title":"The use of nalbuphine in paediatric anaesthesia","volume":"47","author":"Kubica-Cielinska","year":"2015","journal-title":"Anaesth. Intensive Ther."},{"issue":"6","key":"10.1016\/j.lfs.2024.122441_bb0180","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/bja\/aeq082","article-title":"Caudal anaesthesia under sedation: a prospective analysis of 512 infants and children","volume":"104","author":"Brenner","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.lfs.2024.122441_bb0185","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1038\/srep10927","article-title":"A comparision of nalbuphine with morphine for analgesic effects and safety: meta-analysis of randomized controlled trials","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.lfs.2024.122441_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153617","article-title":"Comparison of side effects of nalbuphine and morphine in the treatment of pain in children with cancer: a prospective study","volume":"14","author":"Kubica-Cielinska","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7398","key":"10.1016\/j.lfs.2024.122441_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human kappa-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.lfs.2024.122441_bb0200","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1091\/mbc.E21-04-0177","article-title":"Doxycycline inducible overexpression systems: how to induce your gene of interest without inducing misinterpretations","volume":"32","author":"De Boeck","year":"2021","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lfs.2024.122441_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114653","article-title":"Ligand gated receptor interactions: a key to the power of neuronal networks","volume":"190","author":"Neff","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122441_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front. Mol. Neurosci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T23:27:40Z","timestamp":1717889260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S0024320524000304"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122441","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nalbuphine-6-glucuronide is a potent analgesic with superior safety profiles by altering binding affinity and selectivity for mu-\/kappa-opioid receptors","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122441"}}